Over 1,000 Patients Enrolled in Landmark SELUTION DeNovo Study
- Written by PR Newswire
GENEVA, March 15, 2023 /PRNewswire/ -- MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now a third of the way towards the target of 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel sirolimus drug-eluting balloon [DEB...
